Covered recipient · General Payments record
NEIL E KAY
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2023
$44,522.59
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,900.00 | 5 |
| Food and Beverage | $176.10 | 3 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $2,862.22 | 2 |
| Janssen Biotech, Inc. | $2,160.00 | 1 |
| Janssen Global Services, LLC | $2,078.88 | 3 |
| ABBVIE INC. | $550.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $425.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $550.00 | 03/06/2023 | Consulting Fee | Undisputed | 01/23/2026 | 997617339 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.22 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025027417 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,740.00 | 11/07/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1025036659 | CMS |
| Boston Scientific Corporation | $425.00 | 01/13/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1012116237 | CMS |
| Janssen Biotech, Inc. | $2,160.00 | 06/30/2023 | Consulting Fee | Undisputed | 01/23/2026 | 988227635 | CMS |
| Janssen Global Services, LLC | $2,025.00 | 12/08/2023 | Consulting Fee | Undisputed | 01/23/2026 | 988598849 | CMS |
| Janssen Global Services, LLC | $36.34 | 12/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988598853 | CMS |
| Janssen Global Services, LLC | $17.54 | 12/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988598857 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.